Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

The effect of race/ethnicity on prostate cancer treatment outcome is conditional: a review of Wayne State University data.

Powell IJ, Banerjee M, Bianco FJ, Wood DP Jr, Dey J, Lai Z, Heath M, Pontes EJ.

J Urol. 2004 Apr;171(4):1508-12.

PMID:
15017209
2.

Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):861-8.

3.

[Comparison among patients considered candidates for radical prostatectomy in academic institutes in different countries].

Angulo JC, Akdas A, Eberle JM, Häggman M, Malmstroöm PU, Pontes EJ, Sánchez-Chapado M, Turkeri L, Wood DP Jr.

Arch Esp Urol. 1998 Dec;51(10):957-64. Spanish.

PMID:
9951115
4.

[Survival in stage T2-T3A bladder cancer treated with radical cystectomy].

Angulo Cuesta J, Sánchez Chapado M, Guil Cid M, Flores Corral N, Pontes EJ, Grignon DJ.

Arch Esp Urol. 1997 Jan-Feb;50(1):17-23; discussion 24-5. Spanish.

PMID:
9182484
5.

[Prognosis prediction in patients with transitional cell carcinoma of the urinary bladder].

Angulo Cuesta J, Sánchez Chapado M, Domínguez P, López JI, Flores N, Pontes EJ, Grignon DJ, Montie JE.

Arch Esp Urol. 1996 May;49(4):374-84. Spanish.

PMID:
8754193
6.

Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation.

Forman JD, Duclos M, Shamsa F, Pontes EJ.

Urology. 1996 Mar;47(3):382-6.

PMID:
8633406
7.

Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes EJ, Powell I I, Redman B, Sakr W, Severson R, Tang DG, Wood DP Jr.

Pathol Oncol Res. 1996;2(3):191-211.

8.

Percutaneous nephrostomy using 22-gauge needle technique.

Park HC, Wajsman LZ, Jennings EC, Pontes EJ.

Urology. 1987 May:26-7. No abstract available.

PMID:
3590449
9.

Percutaneous management of upper tract transitional cell carcinoma.

Streem SB, Pontes EJ.

J Urol. 1986 Apr;135(4):773-5.

PMID:
3083119
10.

Rearrangement of chromosome 3 in renal cell carcinoma.

Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Prout GR Jr, Pontes EJ, Huben R, Sandberg AA.

Cancer Genet Cytogenet. 1986 Jan 15;19(3-4):351-4.

PMID:
3943052
11.

Prognostic applications of DNA flow cytometry for human solid tumors.

Frankfurt OS, Arbuck SG, Chin JL, Greco WR, Pavelic ZP, Slocum HK, Mittelman A, Piver SM, Pontes EJ, Rustum YM.

Ann N Y Acad Sci. 1986;468:276-90. No abstract available.

PMID:
3460479
12.
13.

Percutaneous nephrostomy using 22-gauge needle technique.

Park HC, Wajsman LZ, Jennings EC, Pontes EJ.

Urology. 1984 Apr;23(4):388-9. No abstract available.

PMID:
6710716
14.

Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography.

Kirdani RY, Pontes EJ, Murphy GP, Sandberg AA.

J Steroid Biochem. 1984 Jan;20(1):401-6.

PMID:
6200699
15.

Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.

Frankfurt OS, Slocum HK, Rustum YM, Arbuck SG, Pavelic ZP, Petrelli N, Huben RP, Pontes EJ, Greco WR.

Cytometry. 1984 Jan;5(1):71-80.

16.

A micromethod for the measurement of estrogen receptors using high pressure liquid chromatography.

Kirdani RY, Pontes EJ, Murphy GP, Sandberg AA.

J Steroid Biochem. 1982 Sep;17(3):311-7.

PMID:
7132349
17.

Studies of the growth of a murine renal cell carcinoma and its metastatic patterns.

Williams PD, Pontes EJ, Murphy GP.

Res Commun Chem Pathol Pharmacol. 1981 Nov;34(2):345-9.

PMID:
7335958
18.

The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.

Killian CS, Vargas FP, Pontes EJ, Beckley S, Slack NH, Murphy GP, Chu TM.

Prostate. 1981;2(2):187-206.

PMID:
7301655
19.

Double-antibody immunoenzyme assay for human prostatic acid phosphatase.

Choe BK, Pontes EJ, Dong MK, Rose NR.

Clin Chem. 1980 Dec;26(13):1854-9.

20.

Immunoenzyme assay for human prostatic acid phosphatase.

Choe BK, Rose NR, Korol M, Pontes EJ.

Proc Soc Exp Biol Med. 1979 Dec;162(3):396-400. No abstract available.

PMID:
390535
21.

Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification.

McDonald I, Rose NR, Pontes EJ, Choe BK.

Arch Androl. 1978 May;1(3):235-9.

PMID:
83816
22.

Human prostatic acid phosphatases: II. A double--antibody radioimmunoassay.

Choe BK, Pontes EJ, Morrison MK, Rose NR.

Arch Androl. 1978 May;1(3):227-33.

PMID:
83815
23.

Human prostatic acid phosphatases: I. Isolation.

Choe BK, Pontes EJ, Bloink S, Rose NR.

Arch Androl. 1978 May;1(3):221-6.

PMID:
83814
24.

Purification and characterization of human prostatic acid phosphatase.

Choe BK, Pontes EJ, McDonald I, Rose NR.

Prep Biochem. 1978;8(1):73-89.

PMID:
417312
25.

Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.

Choe BK, Pontes EJ, Rose NR, Henderson MD.

Invest Urol. 1978 Jan;15(4):312-8.

PMID:
203554
26.

Immunochemical studies of prostatic acid phosphatase.

Choe BK, Pontes EJ, McDonald I, Rose NR.

Cancer Treat Rep. 1977 Mar-Apr;61(2):201-4.

PMID:
68823

Supplemental Content

Loading ...
Support Center